# MADRIGAL PHARMACEUTICALS, INC. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/madrigal-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 32 | | Claims under review | 1 | | Evidence records | 10 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T13:51:46.791311+00:00 | | Last reviewed | 2026-10-16T13:51:46.791311+00:00 | ## Identity - Legal name: MADRIGAL PHARMACEUTICALS, INC. - Display name: MADRIGAL PHARMACEUTICALS, INC. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T16:05:41.814244+00:00 | | Completeness | 0.409 | | Record Quality | 0.822 | | Directors | 10 | | Committees | 6 | | Governance events | 20 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Bill Sibold: Director. Status: current. Independent: false. Since: 2023-01-01. claim_id=alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:6 - Fred B. Craves, Ph.D.: Director. Status: current. Independent: true. Since: 2016-01-01. claim_id=alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:7 - Jacqualyn A. Fouse, Ph.D.: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Audit (member); Audit; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:8 - James M. Daly: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Audit (member); Audit; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:9 - Julian C. Baker: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Nominating and Governance (chair); Nominating and Governance · Chair (member). claim_id=alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:10 - Kenneth M. Bate: Director. Status: current. Independent: true. Since: 2016-01-01. Committees: Audit (chair); Audit · Chair; Compensation (member); Compensation (member). claim_id=alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:11 - Paul A. Friedman, M.D.: Director. Status: current. Independent: false. Since: 2016-01-01. claim_id=alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:12 - Raymond Cheong, Ph.D., M.D.: Director. Status: current. Independent: true. Since: 2023-01-01. claim_id=alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:13 - Rebecca Taub, M.D.: Director. Status: current. Independent: false. Since: 2016-01-01. claim_id=alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:14 - Richard S. Levy, M.D.: Director. Status: current. Independent: true. Since: 2016-01-01. claim_id=alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:15 ## Committees - Audit (audit). Chair: Kenneth M. Bate. Members: Kenneth M. Bate (chair, current); Jacqualyn A. Fouse, Ph.D. (member, current); James M. Daly (member, current). committee_id=alpha:committee:madrigal-pharmaceuticals-inc:audit - Audit · Chair; Compensation (audit). Chair: NOT_PUBLISHED. Members: Kenneth M. Bate (member, current). committee_id=alpha:committee:madrigal-pharmaceuticals-inc:audit-chair-compensation - Audit; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Jacqualyn A. Fouse, Ph.D. (member, current); James M. Daly (member, current). committee_id=alpha:committee:madrigal-pharmaceuticals-inc:audit-nominating-and-governance - Compensation (compensation). Chair: NOT_PUBLISHED. Members: Kenneth M. Bate (member, current). committee_id=alpha:committee:madrigal-pharmaceuticals-inc:compensation - Nominating and Governance (nominating_governance). Chair: Julian C. Baker. Members: Julian C. Baker (chair, current); Jacqualyn A. Fouse, Ph.D. (member, current); James M. Daly (member, current). committee_id=alpha:committee:madrigal-pharmaceuticals-inc:nominating-and-governance - Nominating and Governance · Chair (nominating_governance). Chair: NOT_PUBLISHED. Members: Julian C. Baker (member, current). committee_id=alpha:committee:madrigal-pharmaceuticals-inc:nominating-and-governance-chair ## Executive leadership - Carole Huntsman: Executive Vice President and Chief Commercial Officer. Status: current. claim_id=alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:17 - David Soergel, M.D.: Executive Vice President and Chief Medical Officer. Status: current. claim_id=alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:19 - Shannon Kelley: Executive Vice President and Chief Legal Counsel. Status: current. claim_id=alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:21 - Bill Sibold: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:16 - David Soergel: Executive Vice President and Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:18 - Mardi Dier: Executive Vice President and Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:20 - Stephen D. Kelley: Executive Vice President and Chief Legal Counsel. Status: unknown. claim_id=alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:22 ## Governance events - EXECUTIVE_APPOINTED: Carole Huntsman executive of MADRIGAL PHARMACEUTICALS, INC., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-16T13:51:46.791311+00:00. event_id=alpha:event:transition:hykq38ja9wo4 - EXECUTIVE_APPOINTED: David Soergel, M.D. executive of MADRIGAL PHARMACEUTICALS, INC., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-16T13:51:46.791311+00:00. event_id=alpha:event:transition:2p0vxx9uuh1r - EXECUTIVE_APPOINTED: Shannon Kelley executive of MADRIGAL PHARMACEUTICALS, INC., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-16T13:51:46.791311+00:00. event_id=alpha:event:transition:hmr845c3llnn - DIRECTOR_APPOINTED: Jacqualyn A. Fouse, Ph.D. seat on MADRIGAL PHARMACEUTICALS, INC., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T13:51:46.791311+00:00. event_id=alpha:event:transition:1ud8m2j1ga0y0n - COMMITTEE_CREATED: Audit; Nominating and Governance committee of MADRIGAL PHARMACEUTICALS, INC., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T13:51:46.791311+00:00. event_id=alpha:event:transition:1suyw6b1icskr3 - COMMITTEE_MEMBER_ADDED: Jacqualyn A. Fouse, Ph.D. member of Audit; Nominating and Governance, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T13:51:46.791311+00:00. event_id=alpha:event:transition:uwazus5gemsa - DIRECTOR_APPOINTED: Bill Sibold seat on MADRIGAL PHARMACEUTICALS, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:51:46.791311+00:00. event_id=alpha:event:transition:rbgdcfgpuean - DIRECTOR_APPOINTED: Julian C. Baker seat on MADRIGAL PHARMACEUTICALS, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:51:46.791311+00:00. event_id=alpha:event:transition:jq35yc9gtwz4 - DIRECTOR_APPOINTED: Raymond Cheong, Ph.D., M.D. seat on MADRIGAL PHARMACEUTICALS, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:51:46.791311+00:00. event_id=alpha:event:transition:8ubd0b5q12ir - COMMITTEE_CREATED: Nominating and Governance · Chair committee of MADRIGAL PHARMACEUTICALS, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:51:46.791311+00:00. event_id=alpha:event:transition:ndmawkyy6tjc - COMMITTEE_MEMBER_ADDED: Julian C. Baker member of Nominating and Governance · Chair, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:51:46.791311+00:00. event_id=alpha:event:transition:8g36xl1yhp77p - DIRECTOR_APPOINTED: James M. Daly seat on MADRIGAL PHARMACEUTICALS, INC., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:51:46.791311+00:00. event_id=alpha:event:transition:1ubmner19ow9k5 - COMMITTEE_MEMBER_ADDED: James M. Daly member of Audit; Nominating and Governance, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:51:46.791311+00:00. event_id=alpha:event:transition:1obdbyea8dbi4 - DIRECTOR_APPOINTED: Fred B. Craves, Ph.D. seat on MADRIGAL PHARMACEUTICALS, INC., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-16T13:51:46.791311+00:00. event_id=alpha:event:transition:wp0sgavqtk64 - DIRECTOR_APPOINTED: Kenneth M. Bate seat on MADRIGAL PHARMACEUTICALS, INC., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-16T13:51:46.791311+00:00. event_id=alpha:event:transition:yzeds71m7bgnz - DIRECTOR_APPOINTED: Paul A. Friedman, M.D. seat on MADRIGAL PHARMACEUTICALS, INC., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-16T13:51:46.791311+00:00. event_id=alpha:event:transition:lfdrzk115bdos - DIRECTOR_APPOINTED: Rebecca Taub, M.D. seat on MADRIGAL PHARMACEUTICALS, INC., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-16T13:51:46.791311+00:00. event_id=alpha:event:transition:1ovtxa41qvimgu - DIRECTOR_APPOINTED: Richard S. Levy, M.D. seat on MADRIGAL PHARMACEUTICALS, INC., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-16T13:51:46.791311+00:00. event_id=alpha:event:transition:wjhot3zxxb6r - COMMITTEE_CREATED: Audit · Chair; Compensation committee of MADRIGAL PHARMACEUTICALS, INC., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-16T13:51:46.791311+00:00. event_id=alpha:event:transition:fbenv3wxsbi7 - COMMITTEE_MEMBER_ADDED: Kenneth M. Bate member of Audit · Chair; Compensation, effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-16T13:51:46.791311+00:00. event_id=alpha:event:transition:8n30zv1uz1zs9 ## Scoped resources - `alpha://company/madrigal-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record - `alpha://company/madrigal-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/madrigal-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/madrigal-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record§ion=board - `alpha://company/madrigal-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/madrigal-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/madrigal-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/madrigal-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/madrigal-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/madrigal-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/madrigal-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/madrigal-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/madrigal-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/madrigal-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/madrigal-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/madrigal-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/madrigal-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/madrigal-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/madrigal-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/madrigal-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record§ion=events - `alpha://company/madrigal-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/madrigal-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/madrigal-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:kenneth-m-bate","name":"Kenneth M. Bate"},"source_id":"board_seats"}` - Claim alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:jacqualyn-a-fouse-phd","name":"Jacqualyn A. Fouse, Ph.D."},"source_id":"board_seats"}` - Claim alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:james-m-daly","name":"James M. Daly"},"source_id":"board_seats"}` - Claim alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:committee_appointment:28: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:kenneth-m-bate","name":"Kenneth M. Bate"},"source_id":"board_seats"}` - Claim alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:committee_appointment:30: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:julian-c-baker","name":"Julian C. Baker"},"source_id":"board_seats"}` - Claim alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:committee_appointment:31: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:jacqualyn-a-fouse-phd","name":"Jacqualyn A. Fouse, Ph.D."},"source_id":"board_seats"}` - Claim alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:committee_appointment:32: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:james-m-daly","name":"James M. Daly"},"source_id":"board_seats"}` ## Leadership - Bill Sibold: Director. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:6. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d. - Fred B. Craves, Ph.D.: Director. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:7. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d. - Jacqualyn A. Fouse, Ph.D.: Director, Audit; Nominating and Governance. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:8. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d. - James M. Daly: Director, Audit; Nominating and Governance. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:9. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d. - Julian C. Baker: Director, Nominating and Governance · Chair. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:10. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d. - Kenneth M. Bate: Director, Audit · Chair; Compensation. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:11. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d. - Paul A. Friedman, M.D.: Director. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:12. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d. - Raymond Cheong, Ph.D., M.D.: Director. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:13. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d. - Rebecca Taub, M.D.: Director. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:14. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d. - Richard S. Levy, M.D.: Director. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:15. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d. - Bill Sibold: President and Chief Executive Officer. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5d780547641484eea1a3ad6c0888572e0c60a10c23a060409c879b470ba661f4. - Carole Huntsman: Executive Vice President and Chief Commercial Officer. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:17. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5491a42f53b0671c41b2f81865ac13ee09dafcdf0befe983a54b80b713ed6ef8. - David Soergel: Executive Vice President and Chief Medical Officer. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c4d18873673d92893df67c0e5b399bec21749abd6b5fe43ec54600af6764d013. - David Soergel, M.D.: Executive Vice President and Chief Medical Officer. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:19. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:04e24728e88c1b8a00af337f57cf0789cf30dbfa6d8410a1cbbf79b90cec664c. - Mardi Dier: Executive Vice President and Chief Financial Officer. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c25f59d3c26a1fba3567fd0b312ff7a0d6b906597b9f1ddc8e4e0eeb7aee4d0f. - Shannon Kelley: Executive Vice President and Chief Legal Counsel. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:21. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9a8eddf995c3be4159b41d68fc3d88c7589b33a53fc6e871458fea98bb68dbbf. - Stephen D. Kelley: Executive Vice President and Chief Legal Counsel. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2fb05eb3c948ea8b025349795f0f422c339d0f4b5e9eb40c06c34607cbfe6201. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Kenneth M. Bate; Members Kenneth M. Bate (Chair); Jacqualyn A. Fouse, Ph.D.; James M. Daly. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:committee_record:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e531d570412dde9d26c9fedfdb97a453f6b5b07d4ebba9225f1b2d0de22afd26. - Compensation: Chair not stated; Members Kenneth M. Bate. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:committee_record:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e531d570412dde9d26c9fedfdb97a453f6b5b07d4ebba9225f1b2d0de22afd26. - Nominating and Governance: Chair Julian C. Baker; Members Julian C. Baker (Chair); Jacqualyn A. Fouse, Ph.D.; James M. Daly. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:committee_record:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e531d570412dde9d26c9fedfdb97a453f6b5b07d4ebba9225f1b2d0de22afd26. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - MADRIGAL PHARMACEUTICALS, INC.. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8075b1d4779f3d841fbecd19f370f3bf681a2a5ed2bca1c4c2f0db3d5804d43d. ## Entity Status - Public listing published. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8075b1d4779f3d841fbecd19f370f3bf681a2a5ed2bca1c4c2f0db3d5804d43d. ## Published Fact - US. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8075b1d4779f3d841fbecd19f370f3bf681a2a5ed2bca1c4c2f0db3d5804d43d. - Healthcare. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8075b1d4779f3d841fbecd19f370f3bf681a2a5ed2bca1c4c2f0db3d5804d43d. ## Committee Appointment - Kenneth M. Bate: chair, Audit. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e531d570412dde9d26c9fedfdb97a453f6b5b07d4ebba9225f1b2d0de22afd26. - Jacqualyn A. Fouse, Ph.D.: member, Audit. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e531d570412dde9d26c9fedfdb97a453f6b5b07d4ebba9225f1b2d0de22afd26. - James M. Daly: member, Audit. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e531d570412dde9d26c9fedfdb97a453f6b5b07d4ebba9225f1b2d0de22afd26. - Kenneth M. Bate: member, Compensation. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:committee_appointment:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e531d570412dde9d26c9fedfdb97a453f6b5b07d4ebba9225f1b2d0de22afd26. - Julian C. Baker: chair, Nominating and Governance. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:committee_appointment:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e531d570412dde9d26c9fedfdb97a453f6b5b07d4ebba9225f1b2d0de22afd26. - Jacqualyn A. Fouse, Ph.D.: member, Nominating and Governance. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:committee_appointment:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e531d570412dde9d26c9fedfdb97a453f6b5b07d4ebba9225f1b2d0de22afd26. - James M. Daly: member, Nominating and Governance. Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:committee_appointment:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e531d570412dde9d26c9fedfdb97a453f6b5b07d4ebba9225f1b2d0de22afd26. ## Security Listing - MDGL (NASDAQ). Claim: alpha:claim:company:a2c6f396-355d-4322-a341-7ad70ce14f80:security_listing:33. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8075b1d4779f3d841fbecd19f370f3bf681a2a5ed2bca1c4c2f0db3d5804d43d. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:8075b1d4779f3d841fbecd19f370f3bf681a2a5ed2bca1c4c2f0db3d5804d43d: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc). - alpha:projection-evidence:document:8ccb69aa66cd3c29faeb05cbbfdae7efb4b3f7a9e16c95735e94a9eee7e6109d: [Madrigal Pharmaceuticals DEF 14A 2025-04-29](https://www.sec.gov/Archives/edgar/data/1157601/000110465925041254/tm2512589-3_def14a.htm). - alpha:projection-evidence:document:5d780547641484eea1a3ad6c0888572e0c60a10c23a060409c879b470ba661f4: MDGL executive roster source. - alpha:projection-evidence:document:5491a42f53b0671c41b2f81865ac13ee09dafcdf0befe983a54b80b713ed6ef8: [MDGL DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1157601/000130817926000352/mdgl-20260428.htm). - alpha:projection-evidence:document:c4d18873673d92893df67c0e5b399bec21749abd6b5fe43ec54600af6764d013: MDGL executive roster source. - alpha:projection-evidence:document:04e24728e88c1b8a00af337f57cf0789cf30dbfa6d8410a1cbbf79b90cec664c: [MDGL DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1157601/000130817926000352/mdgl-20260428.htm). - alpha:projection-evidence:document:c25f59d3c26a1fba3567fd0b312ff7a0d6b906597b9f1ddc8e4e0eeb7aee4d0f: MDGL executive roster source. - alpha:projection-evidence:document:9a8eddf995c3be4159b41d68fc3d88c7589b33a53fc6e871458fea98bb68dbbf: [MDGL DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1157601/000130817926000352/mdgl-20260428.htm). - alpha:projection-evidence:document:2fb05eb3c948ea8b025349795f0f422c339d0f4b5e9eb40c06c34607cbfe6201: MDGL executive roster source. - alpha:projection-evidence:e531d570412dde9d26c9fedfdb97a453f6b5b07d4ebba9225f1b2d0de22afd26: [Audit](https://www.sec.gov/Archives/edgar/data/1157601/000110465925041254/tm2512589-3_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/madrigal-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/madrigal-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/madrigal-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-16T16:05:41.606752+00:00; recorded 2026-10-16T16:05:41.606752+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.